Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Avantor, Inc. AVTR
$20.30
-$0.09 (-0.44%)
На 18:01, 12 мая 2023
+94.29%
Потенциал через год
Ранг: 2
Ключевые показатели
-
Marketcap
13647307573.00000000
-
week52high
33.48
-
week52low
17.91
-
Revenue
7512400000
-
P/E TTM
22
-
Beta
1.33714400
-
EPS
0.92000000
-
Last Dividend
0.00000000
-
Next Earnings Date
26 июл 2023 г. в 10:59
Описание компании
Avantor, Inc. provides products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Avantor, Inc. was founded in 1904 and is headquartered in Radnor, Pennsylvania.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Credit Suisse | Neutral | 25 авг 2022 г. | |
| Raymond James | Outperform | Outperform | 01 авг 2022 г. |
| Morgan Stanley | Overweight | Overweight | 01 авг 2022 г. |
| Citigroup | Neutral | Neutral | 01 авг 2022 г. |
| Baird | Outperform | Outperform | 01 авг 2022 г. |
| Keybanc | Overweight | Overweight | 15 сент 2022 г. |
| Cowen & Co. | Market Perform | Outperform | 14 сент 2022 г. |
| Citigroup | Neutral | Neutral | 14 сент 2022 г. |
| Barclays | Overweight | Overweight | 12 сент 2022 г. |
| Barclays | Overweight | Overweight | 06 окт 2022 г. |
| Baird | Outperform | Outperform | 06 окт 2022 г. |
| Citigroup | Buy | Neutral | 05 окт 2022 г. |
| Morgan Stanley | Overweight | Overweight | 25 окт 2022 г. |
| Raymond James | Outperform | Outperform | 18 окт 2022 г. |
| Goldman Sachs | Buy | Buy | 13 окт 2022 г. |
| Wells Fargo | Overweight | Overweight | 31 окт 2022 г. |
| Raymond James | Outperform | Outperform | 31 окт 2022 г. |
| Morgan Stanley | Overweight | Overweight | 31 окт 2022 г. |
| Baird | Outperform | Outperform | 31 окт 2022 г. |
| Wells Fargo | Overweight | Overweight | 10 янв 2023 г. |
| Deutsche Bank | Hold | 14 дек 2022 г. | |
| Barclays | Overweight | Overweight | 24 янв 2023 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Brophy Gerard | D | 102385 | 11339 | 02 февр 2023 г. |
| Vanderhaegen Frederic | D | 168547 | 2515 | 31 янв 2023 г. |
| Vanderhaegen Frederic | A | 171062 | 44669 | 31 янв 2023 г. |
| Szlosek Thomas A | D | 124574 | 24187 | 31 янв 2023 г. |
| Szlosek Thomas A | A | 148761 | 53636 | 31 янв 2023 г. |
| Miller Justin | D | 98842 | 7942 | 31 янв 2023 г. |
| Miller Justin | A | 106784 | 26818 | 31 янв 2023 г. |
| Stubblefield Michael | D | 1210266 | 91140 | 31 янв 2023 г. |
| Stubblefield Michael | A | 1301406 | 223482 | 31 янв 2023 г. |
| Couturier Christophe | D | 118191 | 7658 | 31 янв 2023 г. |
Новостная лента
Avantor (AVTR) Q1 Earnings Surpass Estimates, Margins Down
Zacks Investment Research
02 мая 2023 г. в 12:57
Despite Avantor's (AVTR) strength in bioproduction and strength in Applied Technologies and Advanced Materials end markets, it reports an overall soft Q1 performance.
Avantor, Inc. (AVTR) Q1 2023 Earnings Call Transcript
Seeking Alpha
28 апр 2023 г. в 14:17
Avantor, Inc. (NYSE:AVTR ) Q1 2023 Earnings Conference Call April 28, 2023 8:00 AM ET Company Participants Christina Jones - Vice President of Investor Relations Michael Stubblefield - President and Chief Executive Officer Thomas Szlosek - Executive Vice President and Chief Financial Officer Conference Call Participants Vijay Kumar - Evercore ISI Patrick Donnelly - Citi Michael Ryskin - Bank of America Rachel Vatnsdal - JPMorgan Dan Brennan - TD Cowen Jack Meehan - Nephron Research Dan Arias - Stifel John Sourbeer - UBS Operator Good morning. My name is Emily, and I will be your conference operator today.
Avantor, Inc. (AVTR) Q1 Earnings and Revenues Beat Estimates
Zacks Investment Research
28 апр 2023 г. в 08:23
Avantor, Inc. (AVTR) came out with quarterly earnings of $0.29 per share, beating the Zacks Consensus Estimate of $0.28 per share. This compares to earnings of $0.38 per share a year ago.
Avantor® to Host First Quarter 2023 Earnings Call on Friday, April 28, 2023
PRNewsWire
04 апр 2023 г. в 08:05
RADNOR, Pa. , April 4, 2023 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, education and government, advanced technologies and applied materials industries, announced that it will release its first quarter 2023 financial results before the market opens on Friday, April 28, and will hold a conference call on the same day at 8:00 a.m.
Here's Why You Should Retain Avantor (AVTR) Stock for Now
Zacks Investment Research
28 мар 2023 г. в 12:58
Investors continue to be optimistic about Avantor's (AVTR) strong product portfolio.